ClinicalTrials.Veeva

Menu

Initial Experience With the AngioVac Venous Drainage Cannula

AngioDynamics logo

AngioDynamics

Status

Completed

Conditions

Heart Disease

Treatments

Device: AngioVac

Study type

Observational

Funder types

Industry

Identifiers

NCT02775565
PV-AV400

Details and patient eligibility

About

This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.

Enrollment

51 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consecutive patients treated at each study site between February 1, 2013 and February 28, 2015 will be included.

Exclusion criteria

  • Patients treated with the AngioVac venous drainage system outside of those dates.

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems